| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,706 |
12,065 |
$2.00M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
487 |
442 |
$958K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,719 |
4,960 |
$926K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,390 |
3,052 |
$431K |
| 71045 |
Radiologic examination, chest; single view |
2,474 |
2,087 |
$353K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,248 |
1,774 |
$305K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,288 |
4,004 |
$279K |
| 71046 |
Radiologic examination, chest; 2 views |
1,419 |
1,220 |
$193K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,597 |
1,846 |
$169K |
| 80053 |
Comprehensive metabolic panel |
15,015 |
11,992 |
$83K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
664 |
613 |
$74K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,526 |
14,993 |
$73K |
| 41115 |
|
98 |
93 |
$52K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
360 |
132 |
$50K |
| 36415 |
Collection of venous blood by venipuncture |
25,776 |
19,168 |
$50K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
620 |
485 |
$44K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
531 |
475 |
$31K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
234 |
61 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,851 |
1,492 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,645 |
2,410 |
$25K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
76 |
67 |
$25K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
16 |
12 |
$24K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
178 |
167 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
582 |
480 |
$22K |
| 80061 |
Lipid panel |
2,195 |
2,043 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
463 |
389 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
718 |
518 |
$15K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
31 |
24 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
281 |
244 |
$13K |
| 81001 |
|
7,365 |
6,354 |
$13K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
120 |
40 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
465 |
382 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
474 |
381 |
$11K |
| 87631 |
|
58 |
23 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
314 |
268 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
689 |
514 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
928 |
719 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,453 |
1,353 |
$7K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
30 |
27 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
661 |
543 |
$5K |
| 85027 |
|
928 |
818 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
38 |
32 |
$4K |
| 84703 |
|
804 |
701 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
165 |
126 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
144 |
59 |
$4K |
| 74018 |
|
28 |
26 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
31 |
30 |
$3K |
| 80081 |
|
44 |
38 |
$2K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
1,275 |
970 |
$2K |
| 83655 |
|
191 |
181 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
131 |
112 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
661 |
523 |
$2K |
| G0378 |
Hospital observation service, per hour |
218 |
89 |
$2K |
| 84484 |
|
233 |
148 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
30 |
27 |
$1K |
| 83605 |
|
220 |
157 |
$1K |
| 83690 |
|
416 |
348 |
$1K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
12 |
$1K |
| 86762 |
|
107 |
96 |
$1K |
| 86780 |
|
120 |
101 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
12 |
$1K |
| 87634 |
|
33 |
32 |
$1K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
86 |
72 |
$975.13 |
| 81025 |
|
278 |
239 |
$970.77 |
| 87660 |
|
52 |
43 |
$757.97 |
| 87480 |
|
52 |
43 |
$737.92 |
| 87510 |
|
52 |
43 |
$737.92 |
| 87340 |
|
106 |
90 |
$675.43 |
| 86803 |
|
53 |
46 |
$621.44 |
| 86850 |
|
159 |
130 |
$562.79 |
| 82043 |
|
118 |
110 |
$547.99 |
| 82728 |
|
74 |
64 |
$501.77 |
| 82570 |
|
106 |
98 |
$450.60 |
| 83735 |
|
88 |
74 |
$415.41 |
| 73630 |
|
12 |
12 |
$380.70 |
| 83550 |
|
76 |
65 |
$335.44 |
| 84439 |
|
68 |
63 |
$330.14 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$306.81 |
| 88143 |
|
19 |
16 |
$291.24 |
| 83540 |
|
75 |
65 |
$264.05 |
| 86900 |
|
119 |
104 |
$256.59 |
| 86901 |
|
119 |
104 |
$256.58 |
| 82077 |
|
12 |
12 |
$184.25 |
| 82607 |
|
14 |
14 |
$180.17 |
| 85730 |
|
24 |
19 |
$118.98 |
| 85610 |
|
24 |
19 |
$84.96 |
| 82950 |
|
12 |
12 |
$55.11 |
| 85014 |
|
12 |
12 |
$39.24 |
| J2704 |
Injection, propofol, 10 mg |
432 |
400 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
373 |
349 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
380 |
355 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
87 |
85 |
$0.00 |
| 83880 |
|
24 |
12 |
$0.00 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
81 |
75 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
385 |
343 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
95 |
82 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
351 |
312 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
431 |
385 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
37 |
37 |
$0.00 |